Intuitive Surgical, Inc. (ETR:IUI1)

Market Cap	133.90B
Revenue (ttm)	7.79B
Net Income (ttm)	2.22B
Shares Out	n/a
EPS (ttm)	6.10
PE Ratio	60.31
Forward PE	50.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	365
Open	367.55
Previous Close	367.45
Day's Range	367.55 - 372.75
52-Week Range	341.55 - 594.40
Beta	n/a
RSI	29.59
Earnings Date	Oct 14, 2025

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 15,638
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: IUI1

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.

Financial numbers in USD